Maha Karnoub
Impact in
Papers in
- Oncology 10
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Michael J. Wagner (1 shared paper)Linda P. Briley (1 shared paper)D. A. Vaske (1 shared paper)H. Sakul (1 shared paper)Daniel K. Burns (1 shared paper)Michael E. Severino (1 shared paper)Callum J. Bell (1 shared paper)Patrick McMillen (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)ESMO Open (1 paper)Archives of Pathology & Laboratory Medicine (1 paper)Genomics (1 paper)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Maha Karnoub
15 papers receiving 387 citations
Peers
Comparison fields: 5 of 48
- Endocrinology, Diabetes and Metabolism 57
- Biochemistry 25
- Surgery 127
- Cancer Research 44
- Genetics 86
Countries citing papers authored by Maha Karnoub
This map shows the geographic impact of Maha Karnoub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Karnoub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Karnoub more than expected).
Fields of papers citing papers by Maha Karnoub
This network shows the impact of papers produced by Maha Karnoub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Karnoub. The network helps show where Maha Karnoub may publish in the future.
Co-authors
The 25 scholars most cited alongside Maha Karnoub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 155 | |
| 2 | 2005 | 104 | |
| 3 | 2015 | 50 | |
| 4 | 2017 | 26 | |
| 5 | 2023 | 25 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2025 | 4 | |
| 10 | 2024 | 3 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2018 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2008 | 0 |
About Maha Karnoub
Maha Karnoub is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 396 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Treatments and Mutations (3 papers), Breast Cancer Treatment Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Epigenetics and DNA Methylation (2 papers), Lung Cancer Research Studies (2 papers) and Nausea and vomiting management (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (57 citations), Biochemistry (25 citations), Surgery (127 citations), Cancer Research (44 citations) and Genetics (86 citations). Maha Karnoub has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Michael J. Wagner, Linda P. Briley, D. A. Vaske, H. Sakul, Daniel K. Burns, Michael E. Severino, Callum J. Bell, Patrick McMillen, Andrew Plump and Eric E. Schadt. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, ESMO Open, Archives of Pathology & Laboratory Medicine and Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.